0
September 01, 2013
AJP CME Course for September 2013: Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder
Expires August 31, 2015
+

Self-Assessment Quiz

Did you know? You can add a subscription now to earn CME Credits!

1.
Weight loss over the course of 16 weeks of metformin treatment in overweight people with schizophrenia and schizoaffective disorder followed which pattern?
2.
Compared to placebo, metformin improved which fasting metabolic measure in overweight people with schizophrenia and schizoaffective disorder?
3.
What side effect was most common in people who received metformin?